These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29691197)

  • 1. A community pharmacy intervention for opioid medication misuse: A pilot randomized clinical trial.
    Cochran G; Field C; Karp J; Seybert AL; Chen Q; Ringwald W; Hruschak V; Chickering S; Kincman J; Jaber A; Tarter R
    J Am Pharm Assoc (2003); 2018; 58(4):395-403. PubMed ID: 29691197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A community pharmacy-led intervention for opioid medication misuse: A small-scale randomized clinical trial.
    Cochran G; Chen Q; Field C; Seybert AL; Hruschak V; Jaber A; Gordon AJ; Tarter R
    Drug Alcohol Depend; 2019 Dec; 205():107570. PubMed ID: 31689641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing opioid medication misuse at point of service in community pharmacy: A study protocol for an interdisciplinary behavioral health trial.
    Cochran G; Shen J; Cox N; Field C; Carlston K; Sengpraseut B; White A; Okifuji A; Jackman C; Haaland B; Ragsdale R; Gordon AJ; Tarter R
    Contemp Clin Trials; 2022 May; 116():106759. PubMed ID: 35417771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief intervention medication therapy management: Establishment of an opioid misuse intervention model delivered in a community pharmacy.
    Kenney A; Cox N; Bryan MA; Cochran G
    Am J Health Syst Pharm; 2021 Feb; 78(4):310-319. PubMed ID: 33386733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
    Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A
    Res Social Adm Pharm; 2019 Aug; 15(8):1047-1055. PubMed ID: 30396825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research.
    Cochran GT; Engel RJ; Hruschak VJ; Tarter RE
    J Pharm Pract; 2017 Oct; 30(5):498-505. PubMed ID: 27402634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies.
    Rao D; Ford JH; Shiyanbola OO
    Addict Sci Clin Pract; 2024 Apr; 19(1):27. PubMed ID: 38589965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
    Riley TB; Alemagno S
    Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.
    Strand MA; Eukel H; Burck S
    Res Social Adm Pharm; 2019 Aug; 15(8):1032-1036. PubMed ID: 30031696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription opioid use: Patient characteristics and misuse in community pharmacy.
    Cochran G; Bacci JL; Ylioja T; Hruschak V; Miller S; Seybert AL; Tarter R
    J Am Pharm Assoc (2003); 2016; 56(3):248-256.e6. PubMed ID: 27053277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive deviants for medication therapy management: A mixed-methods comparative case study of community pharmacy practices.
    Adeoye-Olatunde OA; Lake LM; Strohmier CA; Gourley AK; Ray AR; Zillich AJ; Snyder ME
    Res Social Adm Pharm; 2021 Aug; 17(8):1407-1419. PubMed ID: 33214124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists.
    Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Doucette WR; Hudmon KS; Perkins SM
    Res Social Adm Pharm; 2020 May; 16(5):673-680. PubMed ID: 31439525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What predicts medication therapy management completion rates? The role of community pharmacy staff characteristics and beliefs about medication therapy management.
    Adeoye OA; Lake LM; Lourens SG; Morris RE; Snyder ME
    J Am Pharm Assoc (2003); 2018; 58(4S):S7-S15.e5. PubMed ID: 29731422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tennessee medication therapy management program: A hybrid type 2 effectiveness-implementation trial study protocol.
    Woeppel J; Clark R; Underwood L; Gatwood J; Turner K; Renfro C; Hohmeier KC
    Res Social Adm Pharm; 2020 Mar; 16(3):315-320. PubMed ID: 31151919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.